Navigation Links
Study Determines Breast-Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms
Date:10/2/2007

Dilon high-resolution camera superior to conventional gamma imaging for

both detecting breast cancer and screening high-risk patients.

NEWPORT NEWS, Va., Oct. 2 /PRNewswire/ -- Recently published study results in The Breast Journal indicate that Breast-Specific Gamma Imaging (BSGI) may be more specific than MRI for evaluating patients with equivocal mammographic findings. The study, compiled by Dr. Rachel Brem and colleagues at The George Washington University Medical Center, compared the use of BSGI and MRI for women with an indeterminate mammogram. Standard procedure requires women with an indeterminate mammogram to have additional clinical work-ups.

According to Dr. Brem, Breast Specific Gamma Imaging (BSGI) -- nuclear medicine imaging of the breast -- is a physiologic approach to breast imaging. BSGI uses a high-resolution gamma camera and Tc-Sestamibi. Previous patient examinations demonstrated high-resolution cameras to be superior to conventional gamma imaging for both detecting breast cancer and screening high-risk patients.

"With the advent of high-resolution gamma cameras, further studies of BSGI versus MRI is warranted as both are physiologically-based adjunct imaging modalities for the diagnosis of breast cancer," said Dr. Brem.

Study Methods & Materials

The retrospective study included twenty-three women with an indeterminate breast finding. In these cases, the interpreting radiologist or referring physician had determined BSGI and MRI examinations were necessary. Subsequently, these patients proceeded to biopsy. If a patient's lesion, for which MRI guided biopsy was recommended, was not seen at the time the patient presented for biopsy, then the patient had a short interval follow-up with MRI.

Patients had BSGI with the Dilon 6800 -- a high-resolution, small-field-of-view gamma camera in craniocaudal and mediolateral oblique projections. MRI was performed with a GE 1.5-T system using a dedicated breast coil. The sensitivity, specificity, positive and negative predictive values were calculated for both BSGI and MRI. Statistical significance was determined by comparing the confidence interval of each parameter for BSGI and MRI. All imaging findings were correlated with pathologic diagnosis.

BSGI versus MRI

In the study, thirty-three indeterminate lesions were evaluated. There were a total of 9 pathologically confirmed cancers in 8 patients. Breast MRI resulted in 18 false positive cases while BSGI demonstrated only 7. There was no statistically significant difference in sensitivity of cancer detection between BSGI and MRI. BSGI demonstrated a greater specificity than MRI, 71 percent and 25 percent, respectively.

The study authors concluded, BSGI has comparable sensitivity and greater specificity than MRI for the detection of breast cancer in patients with equivocal mammograms. The smallest cancer detected by BSGI was 3 mm.

Details about BSGI with the Dilon 6800 Gamma Camera

Breast-Specific Gamma Imaging (BSGI), performed with the Dilon 6800, is a molecular breast imaging technique that can see lesions independent of tissue density and thereby discover very early stage cancers. For difficult-to-diagnose patients, BSGI serves as a complementary diagnostic adjunctive procedure to mammography and ultrasound. With BSGI, the patient receives a radioactive tracing agent that is absorbed by all the cells in the body. Cancerous cells in the breast, due to their increased rate of metabolic activity, absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as "hot spots" on BSGI images.

BSGI is ideal for patients with mammograms that are difficult to interpret. The interpretation challenges include dense breast tissue; suspicious areas on a mammogram; lumps that can be felt but not seen with mammography or ultrasound; implants and breast augmentation; scarring from previous surgeries and for women with notable family history of breast cancer.

About Dilon Technologies

Dilon Technologies' signature product is the Dilon 6800 Gamma Camera. Many leading medical centers in the U.S. now offer BSGI, including Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; Northwestern Memorial Hospital, Chicago and The Rose, Houston. For more information on Dilon Technologies please visit http://www.dilon.com.

Breast -- Specific Gamma Imaging with 99mTc-Sestamibi and Magnetic Resonance Imaging in the Diagnosis of Breast Cancer: A Comparative Study The Breast Journal, Volume 13, Issue 5, September 2007 (Rachel F. Brem, MD, Ivan Petrovitch, MD, Jocelyn A. Rapelyea, MD, Heather Young, PhD, Christine Teal, MD, Tricia Kelly, MD).


'/>"/>
SOURCE Dilon Technologies
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: